B. In evaluating the overall security system of a registrant or applicant, the following factors may be considered:

(1) the type of activity;

(2) the quantity of drug precursors;

(3) the location of premises and the relationship such location plays on security needs;

(4) the type of building construction of the facility and the general characteristic of the building;

(5) the adequacy of key control systems and/or lock control systems;

(6) the extent of unsupervised public access to the facility;

(7) the adequacy of supervision over employees having access to storage and distribution areas;

(8) the process for handling business guests, visitors, maintenance personnel, and non-employee service personnel;

(9) the adequacy of the registrant's or applicant's system for monitoring the receipt, manufacture, distribution and disposition of drug precursors in its' operation.

[03-07-80...08-27-90; 16.19.21.26 NMAC - Rn, 16 NMAC 19.21.26, 03-30-02]